Quantbot Technologies LP Acquires Shares of 8,409 Transcat, Inc. $TRNS

Quantbot Technologies LP acquired a new position in shares of Transcat, Inc. (NASDAQ:TRNS) in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 8,409 shares of the scientific and technical instruments company’s stock, valued at approximately $616,000.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in Transcat by 6.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 5,462 shares of the scientific and technical instruments company’s stock worth $407,000 after purchasing an additional 325 shares during the last quarter. Jane Street Group LLC purchased a new stake in Transcat in the 1st quarter valued at about $1,674,000. Envestnet Asset Management Inc. increased its holdings in shares of Transcat by 151.7% during the 2nd quarter. Envestnet Asset Management Inc. now owns 40,818 shares of the scientific and technical instruments company’s stock worth $3,509,000 after buying an additional 24,602 shares during the last quarter. Atria Investments Inc purchased a new stake in shares of Transcat during the 2nd quarter worth about $259,000. Finally, Parkside Financial Bank & Trust purchased a new stake in Transcat during the second quarter worth approximately $79,000. Institutional investors and hedge funds own 98.34% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Transcat in a report on Monday, December 29th. Zacks Research raised shares of Transcat from a “strong sell” rating to a “hold” rating in a research note on Wednesday, March 4th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Transcat presently has a consensus rating of “Moderate Buy” and an average target price of $105.33.

Transcat Trading Down 5.6%

NASDAQ:TRNS opened at $70.67 on Monday. The stock has a fifty day simple moving average of $68.54 and a 200 day simple moving average of $67.82. Transcat, Inc. has a 1-year low of $50.23 and a 1-year high of $97.08. The company has a quick ratio of 1.85, a current ratio of 2.21 and a debt-to-equity ratio of 0.34. The firm has a market capitalization of $659.35 million, a price-to-earnings ratio of 83.14 and a beta of 0.71.

Transcat (NASDAQ:TRNS) last announced its earnings results on Tuesday, February 3rd. The scientific and technical instruments company reported $0.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.30 by ($0.04). Transcat had a net margin of 2.47% and a return on equity of 6.15%. The firm had revenue of $83.86 million for the quarter, compared to analyst estimates of $80.99 million. Sell-side analysts forecast that Transcat, Inc. will post 2.3 earnings per share for the current year.

Transcat Profile

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.